BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16697835)

  • 1. Failure of sacral nerve stimulation due to migration of tined lead.
    Deng DY; Gulati M; Rutman M; Raz S; Rodríguez LV
    J Urol; 2006 Jun; 175(6):2182-5. PubMed ID: 16697835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
    Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
    Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral nerve neuromodulation in patients with cardiac pacemakers.
    Wallace PA; Lane FL; Noblett KL
    Am J Obstet Gynecol; 2007 Jul; 197(1):94.e1-3. PubMed ID: 17618774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience.
    Spinelli M; Giardiello G; Gerber M; Arduini A; van den Hombergh U; Malaguti S
    J Urol; 2003 Nov; 170(5):1905-7. PubMed ID: 14532804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and management of malfunctioning sacral neuromodulator.
    Gaynor-Krupnick DM; Dwyer NT; Rittenmeyer H; Kreder KJ
    Urology; 2006 Feb; 67(2):246-9. PubMed ID: 16461074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium-term experience of sacral neuromodulation by tined lead implantation.
    Van Voskuilen AC; Oerlemans DJ; Weil EH; van den Hombergh U; van Kerrebroeck PE
    BJU Int; 2007 Jan; 99(1):107-10. PubMed ID: 16956350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation in children with dysfunctional elimination syndrome: description of incisionless first stage and second stage without fluoroscopy.
    McGee SM; Routh JC; Granberg CF; Roth TJ; Hollatz P; Vandersteen DR; Reinberg Y
    Urology; 2009 Mar; 73(3):641-4; discussion 644. PubMed ID: 19167048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of sacral neuromodulation in 23 children.
    Humphreys MR; Vandersteen DR; Slezak JM; Hollatz P; Smith CA; Smith JE; Reinberg YE
    J Urol; 2006 Nov; 176(5):2227-31. PubMed ID: 17070300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of success for first stage neuromodulation: motor versus sensory response.
    Cohen BL; Tunuguntla HS; Gousse A
    J Urol; 2006 Jun; 175(6):2178-80; discussion 2180-1. PubMed ID: 16697833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sacral nerve stimulation: Interstim therapy.
    Peeren F; Hoebeke P; Everaert K
    Expert Rev Med Devices; 2005 May; 2(3):253-8. PubMed ID: 16288588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of complications with sacral neuromodulation.
    White WM; Mobley JD; Doggweiler R; Dobmeyer-Dittrich C; Klein FA
    Urology; 2009 Apr; 73(4):731-5. PubMed ID: 19193415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacral nerve neuromodulation (InterStim). Part I: Review of the InterStim system.
    Rittenmeyer H
    Urol Nurs; 2008 Feb; 28(1):15-20. PubMed ID: 18335692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial.
    Peters KM; Feber KM; Bennett RC
    Neurourol Urodyn; 2005; 24(7):643-7. PubMed ID: 16178000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral caudal epidural neuromodulation for refractory urinary retention: a salvage procedure.
    Maher MG; Mourtzinos A; Zabihi N; Laiwalla UZ; Raz S; Rodríguez LV
    J Urol; 2007 Jun; 177(6):2237-40; discussion 2241. PubMed ID: 17509329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sacral nerve stimulator revision due to somatic growth.
    Clark C; Ngo T; Comiter CV; Anderson R; Kennedy W
    J Urol; 2011 Oct; 186(4 Suppl):1576-80. PubMed ID: 21855923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children.
    Roth TJ; Vandersteen DR; Hollatz P; Inman BA; Reinberg YE
    J Urol; 2008 Jul; 180(1):306-11; discussion 311. PubMed ID: 18499169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?
    Kessler TM; Madersbacher H; Kiss G
    Eur Urol; 2005 May; 47(5):660-5. PubMed ID: 15826759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety.
    Spinelli M; Sievert KD
    Eur Urol; 2008 Dec; 54(6):1287-96. PubMed ID: 18336992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data.
    Spinelli M; Malaguti S; Giardiello G; Lazzeri M; Tarantola J; Van Den Hombergh U
    Neurourol Urodyn; 2005; 24(4):305-9. PubMed ID: 15977260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian experience in sacral neuromodulation.
    Elkelini M; Hassouna MM
    Urol Clin North Am; 2005 Feb; 32(1):41-9. PubMed ID: 15698875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.